Twist Bioscience (TWST) Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Current Assets for 9 consecutive years, with $323.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets fell 4.43% year-over-year to $323.4 million; the TTM figure through Mar 2026 stood at $323.4 million (down 4.43% YoY), while the FY2025 annual figure was $333.0 million, down 3.98% from the prior year.
• Current Assets climbed to $323.4 million in Q1 2026 per TWST's latest filing, from $303.9 million in the prior quarter.
• Across five years, Current Assets topped out at $664.4 million in Q1 2022 and bottomed at $303.9 million in Q4 2025.
• Historically, Current Assets has averaged $425.9 million across 5 years, with a median of $371.9 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets surged 40.74% — and 2023, when it slipped 28.87%.
• Twist Bioscience's Current Assets stood at $541.9 million in 2022, then slipped by 27.98% to $390.2 million in 2023, then declined by 11.51% to $345.3 million in 2024, then declined by 12.0% to $303.9 million in 2025, then advanced by 6.44% to $323.4 million in 2026.
• Business Quant data shows TWST's Current Assets at $323.4 million in Q1 2026, $303.9 million in Q4 2025, and $333.0 million in Q3 2025.